Autoantibody to PL-12 (Anti-Alanyl-tRNA Synthetase) in an African American Girl with Juvenile Dermatomyositis and Resolution of Interstitial Lung Disease
暂无分享,去创建一个
[1] L. Pachman,et al. Mycophenolate mofetil: A possible therapeutic agent for children with juvenile dermatomyositis , 2010, Arthritis care & research.
[2] S. Sahn,et al. Clinical profile of anti-PL-12 autoantibody. Cohort study and review of the literature. , 2009, Chest.
[3] B. Feldman,et al. Juvenile dermatomyositis and other idiopathic inflammatory myopathies of childhood , 2008, The Lancet.
[4] L. Pachman,et al. Pharmacokinetic study of oral prednisolone compared with intravenous methylprednisolone in patients with juvenile dermatomyositis. , 2008, Arthritis and rheumatism.
[5] A. Paller,et al. Persistent association of nailfold capillaroscopy changes and skin involvement over thirty-six months with duration of untreated disease in patients with juvenile dermatomyositis. , 2008, Arthritis and rheumatism.
[6] P. Lachenbruch,et al. Validation and clinical significance of the Childhood Myositis Assessment Scale for assessment of muscle function in the juvenile idiopathic inflammatory myopathies. , 2004, Arthritis and rheumatism.
[7] B. V. van Engelen,et al. Myositis-specific autoantibodies: overview and recent developments , 2001, Current opinion in rheumatology.
[8] M. Wener,et al. A broadened spectrum of juvenile myositis. Myositis-specific autoantibodies in children. , 1994, Arthritis and rheumatism.
[9] R. Petty,et al. Monitoring disease activity in juvenile dermatomyositis: the role of von Willebrand factor and muscle enzymes. , 1994, The Journal of rheumatology.
[10] M. Dalakas,et al. A New Approach to the Classification of Idiopathic Inflammatory Myopathy: Myositis‐Specific Autoantibodies Define Useful Homogeneous Patient Groups , 1991, Medicine.
[11] P. Malleson. Controversies in juvenile dermatomyositis. , 1990, The Journal of rheumatology. Supplement.
[12] F. Arnett,et al. Clinical manifestations in patients with antibody to PL-12 antigen (alanyl-tRNA synthetase). , 1990, The American journal of medicine.
[13] S. Gabriel,et al. NSAID induced ulcers. An emerging epidemic? , 1990, The Journal of rheumatology.
[14] L. Pachman,et al. Juvenile dermatomyositis: a clinical and immunologic study. , 1980, The Journal of pediatrics.
[15] E. Huskisson,et al. Anti- inflammatory, , 2022 .